Diagnosis and Management of Cerebral Venous Thrombosis

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 272

Special Issue Editor


E-Mail Website
Guest Editor
Department of Neurological Surgery, Keck School of Medicine of USC, Los Angeles, CA, USA
Interests: vascular neurology; thrombus aspiration; brain ischemia; solitaire neurological manifestation; cerebral venous sinus thrombosis; stroke; imaging; cerebral venography

Special Issue Information

Dear Colleagues,

The purpose of our special issue is to provide an overview of cerebral venous sinus thrombosis and to provide evidence-based recommendations for its diagnosis and management. Cerebrovenous thrombosis (CVST) accounts for only 0.5% of all strokes. It has variable clinical presentation and it's diagnosis might be challenging at times. Delays in timely diagnosis and treatment initiation might lead to poor neurological outcome. A clinical suspicion in conjunction with neuroradiological diagnostic support are required in the diagnosis. Our special issue focus on current knowledge on the risk factors, challenges with diagnosis, neuro-imaging, management options with focus on the role of endovascular mechanical thrombectomy , thrombolytic therapy and direct oral anticoagulants and also prognosis of CVST in adults, and highlights some areas for future research.

Dr. Mowla Ashkan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cerebral venous sinus thrombosis
  • dural sinus thrombosis
  • anticoagulation
  • stroke
  • imaging
  • cerebral venography
  • heparin
  • endovascular treatment
  • direct oral anticoagulants

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop